PRO-DEX, INC. Depreciation
PRO-DEX, INC. (PDEX) reported Depreciation of $1.20 million for the 12-month period ending 2026-06-30, per its 10-K filed 2026-09-03.
Financial Statements › Cash Flow › Operating Activities
us-gaap:Depreciation · last filed 2026-09-03
- PRO-DEX, INC. depreciation for the quarter ending 2025-06-30 was $1.03M, a 10.75% increase year-over-year.
- PRO-DEX, INC. depreciation for the quarter ending 2025-03-31 was $23.00K, a 0.00% change year-over-year.
- PRO-DEX, INC. depreciation for the quarter ending 2024-06-30 was $930.00K, a 41.55% increase year-over-year.
- PRO-DEX, INC. depreciation for the quarter ending 2024-03-31 was $23.00K, a 0.00% change year-over-year.
- PRO-DEX, INC. depreciation for fiscal 2026 was $1.20M, a 9.09% increase from fiscal 2025.
- PRO-DEX, INC. depreciation for fiscal 2025 was $1.10M, a 10.00% increase from fiscal 2024.
- PRO-DEX, INC. depreciation for fiscal 2024 was $1.00M, a 37.55% increase from fiscal 2023.
- PRO-DEX, INC. depreciation for fiscal 2023 was $727.00K, a 18.02% increase from fiscal 2022.
| Period end | Depreciation 3 month | Depreciation 6 month | Depreciation 9 month | Depreciation 12 month | Depreciation 12 month as first filed |
|---|---|---|---|---|---|
| 2026-06-30 | $1.20M 10-K · filed 2026-09-03 | ||||
| 2025-06-30 | $1.03M derived: 10-K 12 month − 10-Q 9 month · filed 2026-09-03 | $1.05M derived: sum of 2 quarters · filed 2026-09-03 | $1.10M 10-K · filed 2026-09-03 | ||
| 2025-03-31 | $23.00K 10-Q · filed 2025-05-01 | $70.00K 10-Q · filed 2025-05-01 | |||
| 2024-06-30 | $930.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-09-04 | $953.00K derived: sum of 2 quarters · filed 2025-09-04 | $1.00M 10-K · filed 2025-09-04 | $1.04M 10-K · filed 2024-09-05 | |
| 2024-03-31 | $23.00K 10-Q · filed 2025-05-01 | $70.00K 10-Q · filed 2025-05-01 | |||
| 2023-06-30 | $657.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-09-05 | $680.00K derived: sum of 2 quarters · filed 2024-09-05 | $727.00K 10-K · filed 2024-09-05 | ||
| 2023-03-31 | $23.00K 10-Q · filed 2024-05-02 | $70.00K 10-Q · filed 2024-05-02 | |||
| 2022-06-30 | $616.00K 10-K · filed 2023-10-13 | ||||
| 2021-06-30 | $609.00K 10-K · filed 2022-09-08 | ||||
| 2020-06-30 | $559.00K 10-K · filed 2021-09-09 | ||||
| 2019-06-30 | $416.00K 10-K · filed 2020-09-10 | ||||
| 2018-06-30 | $522.00K 10-K · filed 2019-09-12 | ||||
| 2017-06-30 | $505.00K 10-K · filed 2018-09-13 | ||||
| 2016-06-30 | $486.00K 10-K · filed 2017-09-14 | $497.00K 10-K · filed 2016-09-15 | |||
| 2015-06-30 | $534.00K 10-K · filed 2016-09-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| UTAH MEDICAL PRODUCTS INC (UTMD) | United States | $0.238B | 20.93 |
| Neuronetics, Inc. (STIM) | United States | $0.216B | -3.25 |
| InfuSystem Holdings, Inc (INFU) | United States | $0.253B | 22.52 |
| Profound Medical Corp. (PROF) | $0.206B | -7.37 | |
| Anika Therapeutics, Inc. (ANIK) | United States | $0.272B | -51.71 |
| ORASURE TECHNOLOGIES INC (OSUR) | United States | $0.272B | -6.26 |
| Cytosorbents Corp (CTSO) | United States | $0.274B | -1.29 |
| TriSalus Life Sciences, Inc. (TLSI) | United States | $0.283B | -9.92 |
| Mobia Medical, Inc. (MOBI) | United States | $0.293B | |
| TREACE MEDICAL CONCEPTS, INC. (TMCI) | United States | $0.297B | -4.32 |